20/20 GeneSystems Revenue and Competitors

Location

$14.4M

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • 20/20 GeneSystems's estimated annual revenue is currently $2.6M per year.(i)
  • 20/20 GeneSystems's estimated revenue per employee is $77,520
  • 20/20 GeneSystems's total funding is $14.4M.

Employee Data

  • 20/20 GeneSystems has 34 Employees.(i)
  • 20/20 GeneSystems grew their employee count by -8% last year.

20/20 GeneSystems's People

NameTitleEmail/Phone
1
Chief Operating OfficeReveal Email/Phone
2
CLIA Medical DirectorReveal Email/Phone
3
President & CEOReveal Email/Phone
4
BioAnalyticsReveal Email/Phone
5
Business Development, ChinaReveal Email/Phone
6
Business Development, U.SReveal Email/Phone
7
General SupervisorReveal Email/Phone
8
Sales RepresentativeReveal Email/Phone
9
National Business Development ManagerReveal Email/Phone
10
Clinical Laboratory TechnicianReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.9M77N/AN/AN/A
#2
$557.1M39015%N/AN/A
#3
$4M49-6%N/AN/A
#4
$3.8M467%N/AN/A
#5
$2.6M35N/AN/AN/A
#6
$21M187N/AN/AN/A
#7
$2.1M29-19%N/AN/A
#8
$279.6M1958N/AN/AN/A
#9
$67.1M5265%N/AN/A
#10
$706.1M4945N/AN/AN/A
Add Company

What Is 20/20 GeneSystems?

20/20 GeneSystems (www.2020gene.com), based in Rockville, MD, was founded in May 2000 to co-develop the P-FILM technology with the National Cancer Institute. The privately held company maintains exclusive rights to this technology.

keywords:N/A

$14.4M

Total Funding

34

Number of Employees

$2.6M

Revenue (est)

-8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

20/20 GeneSystems News

2022-04-19 - Bio-Detection Market Report 2022 – Players, Countries, Type ...

20/20 GeneSystems BioVeris. General Dynamics Canada BioSentinel Pharmaceuticals Smiths Group BD Biosciences Immunocytometry Systems

2022-04-17 - Cancer Testing/ Screening Market Size, Share and Trends ...

... Forecast Key Players | Dias Orin, Epigenetics, Techlab, Positive Bioscience, Genextropy, M Genomics, 20/20 GeneSystems, AB SCIEX, A…

2016-01-14 - 20/20 GeneSystems Raises $4.5M in Series A Equity Funding

20/20 GeneSystems, Inc., a Rockville, Maryland-based developer of tumor biomarker diagnostics via big-data healthcare analytics, raised $4.5m in new Series A equity funding. Backers included Ping An Ventures and several family offices and individual investors, many affiliated with the Keiretsu ...

2007-10-10 - Life sciences briefing: Wednesday, Oct. 10, 2007

Featured companies: 20/20 GeneSystems, Bellicum Pharmaceuticals, Cumbre Pharmaceuticals, Dara BioSciences, Enterprise Partners Venture Capital, Fermentas, International, Iasis Medical, New Leaf Venture Partners, Point Therapeutics, Power Medical Interventions, Rules-Based Medicine, Spinal Restor ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.9M34-3%N/A
#2
$2.7M340%N/A
#3
$15M340%N/A
#4
$6M34-19%N/A
#5
$7.3M34-13%N/A